10 results on '"Vachier, Isabelle"'
Search Results
2. eo-Drive
- Author
-
Bourdin, Arnaud, Suehs, Carey, Vachier, Isabelle, Molinari, Nicolas, Chanez, Pascal, Roche, Nicolas, Burgel, Pierre-Régis, Chinet, Thierry, Demoule, Alexandre, Similowski, Thomas, Morelot, Capucine, Londner, Cecile, Chenivesse, Cecile, Le Rouzic, Olivier, Bautin, Nathalie, Perez, Thierry, Raherison, Chantal, Molimard, Mathieu, Berger, Patrick, Girodet, Pierre, Yali, Matthieu, Devouassoux, Gilles, Didier, Alain, Noel-Savina, Elise, Couturaud, Francis, DESLEE, Chabaud, François, Chaouat, Ari, Guillaumot, Anne, Zysman, Maeva, Devillier, Philippe, Kessler, Romain, Just, Nicolas, Gamez, Anne-Sophie, and Boyer, Laurent
- Subjects
exacerbation ,biomarker driven ,COPD ,eosinophilia ,corticosteroids ,hospitalization - Published
- 2022
- Full Text
- View/download PDF
3. Sputum-Rheology-Based Strategy for Guiding Azithromycin Prescription in COPD Patients with Frequent Exacerbations: A Randomized, Controlled Study ("COPD CARhE").
- Author
-
Charriot, Jeremy, Zysman, Maeva, Guilleminault, Laurent, Volpato, Mathilde, Fort-Petit, Aurelie, Vachier, Isabelle, Patarin, Jeremy, Suehs, Carey, Ahmed, Engi, Molinari, Nicolas, and Bourdin, Arnaud
- Subjects
CHRONIC obstructive pulmonary disease ,AZITHROMYCIN ,DISEASE exacerbation ,LUNG diseases ,MEDICAL prescriptions ,PULMONARY eosinophilia - Abstract
(1) Background: We have previously shown that sputum rheology can discriminate between patients with COPD and other muco-obstructive lung diseases, and that it is correlated with mucin content and sputum eosinophilia. We now hypothesize that it could be a more-accurate guide than clinical evaluation for the prescription of azithromycin to prevent exacerbations of COPD and to reduce exposure to antibiotics; (2) Methods: "COPD CaRhe" is a multicentric, randomized, controlled trial comparing outcomes in two parallel arms (36 vs. 36 patients). Patients will be recruited in the university hospitals of Montpellier, Bordeaux, and Toulouse, in France, and they should have a diagnosis of COPD with frequent exacerbations (≥3/year). Enrollment will occur during a routine visit to a respiratory department, and follow-up visits will occur every 3 months for a period of 1 year. At each visit, a 3-month prescription of azithromycin will be provided to those patients who obtain a score of <70 on the Cough and Sputum Assessment Questionnaire (CASA-Q) or a critical stress score of σc > 39 on a rheological assessment of sputum, depending upon their randomization group. The primary outcome will be the number of exacerbations of COPD; (3) Discussion: By using sputum rheology, the COPD CaRhe study may provide clinicians with an objective biomarker to guide the prescription of azithromycin while reducing the cumulative exposure to macrolides. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Rhéologie du mucus à partir d'un modèle d'épithélium bronchique Humain
- Author
-
JORY, Myriam, Blanc, Christophe, Fort, Aurélie, DONNARUMMA, Dario, CASANELLAS VILAGELIU, Laura, Vachier, Isabelle, Bourdin, Arnaud, MASSIERA, Gladys, Laboratoire Charles Coulomb (L2C), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Matière Molle, Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Service d'allergologie et de pneumologie [Hôpital Arnaud de Villeneuve], Centre Hospitalier Universitaire de Montpellier (CHU Montpellier ), Vaincre la Mucoviscidose, and Projet de thèse: 'Approche biophysique de la fonction mucociliaire: rhéologie du mucus et coordination ciliaireCollaboration avec le CHU de Montpellier
- Subjects
Mucus ,Human bronchial epithelium ,Optical Tweezers ,[PHYS.PHYS.PHYS-BIO-PH]Physics [physics]/Physics [physics]/Biological Physics [physics.bio-ph] ,Micro rheology ,Adhesion ,COPD ,Macro Rheology - Abstract
National audience; La fonction mucociliaire de l'épithélium bronchique assure le nettoyage continu des voies respiratoires afin d’éviter toutes infections et inflammations par les éléments présents dans l’air que nous respirons. L'efficacité de la clairance mucociliaire repose sur deux éléments principaux : les propriétés rhéologiques du mucus et la coordination du battement ciliaire. Dans cette communication, nous décrirons spécifiquement nos résultats sur la rhéologie du mucus. Notre approche biophysique vise à comprendre les paramètres biochimiques et physiques affectant les propriétés viscoélastiques du mucus et à évaluer l 'utilisation des propriétés viscoélastiques du mucus comme marqueur du diagnostic de maladie respiratoire (BPCO, maladie pulmonaire obstructive chronique ...).Des études sur la rhéologie du mucus ont déjà été réalisées, mais essentiellement sur le crachat ou le mucus reconstitué. Nous avons effectué des expériences rhéologiques sur le mucus extrait des cultures ALI (Air Liquid Interface) de l'épithélium bronchique reconstitué à partir d'une biopsie bronchique. Notre approche consiste à combiner une expérience de macro-rhéologie standard et une micro-rhéologie réalisée avec des pinces optiques afin de quantifier les propriétés viscoélastiques du mucus et de comprendre son comportement d'écoulement à différentes échelles, de l'échelle des cils jusqu'à l'échelle de longueur sur laquelle le mucus est transporté.Nos résultats montrent le comportement d'amincissement par cisaillement et la nature élastique du mucus avec un petit module élastique G 'compris entre 1 et 2 Pa. On observe également la rupture du gel de mucus à très faible taux de cisaillement et même pour la déformation oscillatoire réalisée À des fréquences inférieures à la fréquence de battement des cils (~ 15 Hz), probablement en raison de la structure complexe et hétérogène du mucus. Néanmoins, la structure du mucus et les propriétés viscoélastiques sont récupérées en 5 minutes. La macro et la micro-rhéologie indiquent deux comportements différents : on observe un plateau élastique à la macro-échelle et un comportement visqueux à la micro-échelle, avec une viscoélasticité très faible de l'ordre de 10-3 à 10-2 Pa et proportionnelle À la fréquence de ω0,9 dans la même plage de fréquence. En appliquant des forces locales grâce à des pinces optiques, comme le montre la figure 1, nous montrons que l'adhérence du mucus est impliquée et doit être prise en compte pour comprendre les différences entre les propriétés mécaniques mesurées à ces différentes échelles de longueur et plus généralement pour caractériser les propriétés du mucus.Cette approche biophysique et méthodologie spécifique nous permet de comparer des échantillons correspondant à différentes pathologies du patient et pourrait être appliquée avec succès à l'hypersécrétion de mucus de patients atteints de fibrose kystique. Ce travail s'inscrit dans le cadre d'un projet de plus grande envergure impliquant une étude de physique statistique sur la coordination des cils et son couplage avec la viscoélasticité du mucus.
- Published
- 2017
5. Rising total costs and mortality rates associated with admissions due to COPD exacerbations
- Author
-
Molinari , Nicolas, Chanez , Pascal, Roche , Nicolas, Ahmed , Engi, Vachier , Arnaud, Bourdin , Arnaud, Vachier , Isabelle, Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Institut National de la Recherche Agronomique (INRA)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Pneumologie et Soins Intensifs Respiratoires, Université Paris Descartes - Paris 5 (UPD5)-Hôpitaux Universitaires Paris Centre, Cellules Souches, Plasticité Cellulaire, Médecine Régénératrice et Immunothérapies (IRMB), Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Département pneumologie et addictologie [Montpellier], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Arnaud de Villeneuve, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] ( PhyMedExp ), Centre National de la Recherche Scientifique ( CNRS ) -Université de Montpellier ( UM ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Centre Hospitalier Régional Universitaire [Montpellier] ( CHRU Montpellier ), Centre recherche en CardioVasculaire et Nutrition ( C2VN ), Institut National de la Recherche Agronomique ( INRA ) -Aix Marseille Université ( AMU ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Université Paris Descartes - Paris 5 ( UPD5 ) -Hôpitaux Universitaires Paris Centre, CHU Saint-Eloi-Centre Hospitalier Régional Universitaire [Montpellier] ( CHRU Montpellier ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université de Montpellier ( UM ), Centre Hospitalier Régional Universitaire [Montpellier] ( CHRU Montpellier ) -Hôpital Arnaud de Villeneuve, MORNET, Dominique, and Centre recherche en CardioVasculaire et Nutrition (C2VN)
- Subjects
Male ,Time Factors ,Databases, Factual ,medicine.medical_treatment ,[SDV]Life Sciences [q-bio] ,Severity of Illness Index ,Pulmonary Disease, Chronic Obstructive ,0302 clinical medicine ,Patient Admission ,Risk Factors ,030212 general & internal medicine ,Hospital Mortality ,Longitudinal Studies ,Registries ,Hospital Costs ,health care economics and organizations ,ComputingMilieux_MISCELLANEOUS ,Aged, 80 and over ,COPD ,Mortality rate ,Incidence (epidemiology) ,Incidence ,Process Assessment, Health Care ,Middle Aged ,3. Good health ,[SDV] Life Sciences [q-bio] ,Treatment Outcome ,Disease Progression ,Female ,France ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Critical Care ,education ,macromolecular substances ,Bronchoscopies ,03 medical and health sciences ,COPD exacerbation ,Severity of illness ,medicine ,Humans ,Intensive care medicine ,Admissions ,Aged ,Mechanical ventilation ,Hospitalizations ,[ SDV ] Life Sciences [q-bio] ,business.industry ,Research ,COPD management ,Length of Stay ,medicine.disease ,Respiration, Artificial ,respiratory tract diseases ,Pneumonia ,030228 respiratory system ,Copd exacerbation ,Deaths ,Emergency medicine ,business - Abstract
Background To examine trends in mortality, costs and in-hospital management and outcomes of severe COPD exacerbations admitted in France. Methods Patients hospitalized from 2007 to 2012 with COPD exacerbation as the primary diagnosis were identified from the exhaustive French medico-administrative hospitalizations database records. Four groups of severe COPD exacerbations were defined: hospitalisation in a general ward (GW) without acute respiratory failure (ARF), GW with ARF, ICU without invasive mechanical ventilation (MV), and ICU with MV. Results A 15.48 % increase in admissions from 113 276 in 2007 to 133 497 in 2012 was recorded. Age (+9.9 months), gender (−2.5 % of male) and length of stay (−0.29 day) slightly changed while the number of ICU admissions increased markedly (+41.78 %). In-hospital mortality rates increased (+8.06 %, p
- Published
- 2016
6. CCSP G38A polymorphism environment interactions regulate CCSP levels differentially in COPD.
- Author
-
Knabe, Lucie, Varilh, Jessica, Bergougnoux, Anne, Gamez, Anne-Sophie, Bonini, Jennifer, Pommier, Alexandra, Petit, Aurélie, Molinari, Nicolas, Vachier, Isabelle, Taulan-Cadars, Magali, and Bourdin, Arnaud
- Subjects
GENETIC polymorphisms ,OBSTRUCTIVE lung diseases ,TRANSCRIPTION factors ,CIGARETTE smoke ,BODY mass index ,GENE transfection ,DYSPNEA - Abstract
Impaired airway homeostasis in chronic obstructive pulmonary disease (COPD) could be partly related to club cell secretory protein (CCSP) deficiency. We hypothesize that CCSP G38A polymorphism is involved and aim to examine the influence of the CCSP G38A polymorphism on CCSP transcription levels and its regulatory mechanisms. CCSP genotype and CCSP levels in serum and sputum were assessed in 66 subjects with stable COPD included in a 1-yr observational study. Forty-nine of them had an exacerbation. In an in vitro study, the impact on the CCSP promoter of 38G wild-type or 38A variant was assessed. BEAS-2B cells were transfected by either the 38G or 38A construct, in the presence/absence of cigarette smoke extract (CSE) or lipopolysaccharides (LPS). Cotransfections with modulating transcription factors, p53 and Nkx2.1, identified by in silico analysis by using ConSite and TFSEARCH were conducted. A allele carrier COPD patients had lower serum and sputum CCSP levels, especially among active smokers, and a decreased body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) score. In vitro, baseline CCSP transcription levels were similar between the wild and variant constructs. CSE decreased more profoundly the CCSP transcription level of 38A transfected cells. The opposite effect was observed with p53 cotransfection. LPS stimulation induced CCSP repression in 38A promoter transfected cells. Cotransfection with Nkx2.1 significantly activated the CCSP promoters irrespective of the polymorphism. Circulating CCSP levels are associated with smoking and the CCSP G38A polymorphism. CSE, LPS, and the Nkx2.1 and p53 transcription factors modulated the CCSP promoter efficiency. The 38A polymorphism exaggerated the CCSP repression in response to p53 and CSE. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
7. Is generalization of exhaled CO assessment in primary care helpful for early diagnosis of COPD?
- Author
-
Molinari, Nicolas, Abou-Badra, Mathieu, Marin, Grégory, Chin-Long Ky, Amador, Noemi, Gamez, Anne Sophie, Vachier, Isabelle, and Bourdin, Arnaud
- Subjects
OBSTRUCTIVE lung disease diagnosis ,PRIMARY care ,SPIROMETRY ,CARBON monoxide ,DISEASE risk factors - Abstract
Background: COPD is largely under-diagnosed and once diagnosed usually at a late stage. Early diagnosis is thoroughly recommended but most attempts failed as the disease is marginally known and screening marginally accepted. It is a rare cause of concern in primary care and spirometry is not very common. Exhaled carbon monoxide (eCO) is a 5-seconds easy-to-use device dedicated to monitor cigarette smoke consumption. We aimed to assess whether systematic eCO measurement in primary care is a useful tool to improve acceptance for early COPD diagnosis. Methods: This was a two-center randomized controlled trial enrolling 410 patients between March and May, 2013. Whatever was the reason of attendance to the clinic, all adults were proposed to measure eCO during randomly chosen days and outcomes were compared between the two different groups of patients (performing and not performing eCO). Primary outcome was the rates of acceptance for COPD screening. Results: Rate of acceptance for COPD screening was 28% in the eCO group and 26% in the other (P = 0.575). These rates increased to 48 and 51% in smokers (current and former). eCO significantly increased the rate of clinics during which a debate on smoking was initiated (42 vs. 24%, P = 0.001). eCO at 2.5 ppm was the discriminative concentration for identifying active smokers (ROC curve AUC: 0.935). Smoking was the only independent risk factor associated with acceptance for early COPD screening (OR = 364.6 (82.5-901.5) and OR = 78.5 (18.7-330.0) in current and former smokers, respectively) while eCO measurement was not. Conclusions: Early COPD diagnosis is a minor cause of concern in primary care. Systematic eCO assessment failed to improve acceptance for early COPD screening. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
8. Roles of Mesenchymal Cells in the Lung: From Lung Development to Chronic Obstructive Pulmonary Disease.
- Author
-
Nasri, Amel, Foisset, Florent, Ahmed, Engi, Lahmar, Zakaria, Vachier, Isabelle, Jorgensen, Christian, Assou, Said, Bourdin, Arnaud, and De Vos, John
- Subjects
CHRONIC obstructive pulmonary disease ,LUNG development ,LUNG diseases - Abstract
Mesenchymal cells are an essential cell type because of their role in tissue support, their multilineage differentiation capacities and their potential clinical applications. They play a crucial role during lung development by interacting with airway epithelium, and also during lung regeneration and remodeling after injury. However, much less is known about their function in lung disease. In this review, we discuss the origins of mesenchymal cells during lung development, their crosstalk with the epithelium, and their role in lung diseases, particularly in chronic obstructive pulmonary disease. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
9. Specificity of basement membrane thickening in severe asthma.
- Author
-
Bourdin, Arnaud, Neveu, Dorine, Vachier, Isabelle, Paganin, Fabrice, Godard, Philippe, and Chanez, Pascal
- Subjects
ASTHMA ,OBSTRUCTIVE lung diseases ,ADRENOCORTICAL hormones ,RESPIRATORY obstructions - Abstract
Background: Reticular basement membrane (RBM) thickness is considered a hallmark for airway remodeling in airway diseases such as asthma. It is still unclear whether this measurement could be associated with disease severity or apply to chronic obstructive pulmonary disease (COPD). A wide range of results, at baseline or after therapeutic intervention, have been reported using different measurement methods. Objective: To determine whether increased RBM thickness could be associated specifically with severe asthma and in COPD in large samples. Methods: We blindly measured RBM thickness in endobronchial biopsies from 50 patients with severe asthma (mean age, 53 years; FEV
1 66% predicted, inhaled steroids ≥1500 μg and 20 mg daily dose of oral corticosteroids, lifelong nonsmokers), 50 untreated patients with mild asthma (mean age, 33 years; FEV1 93%pred, lifelong nonsmokers), 50 patients with COPD (mean age, 57 years; FEV1 53%pred, all current smokers), and 18 control subjects using 2 different validated quantitative and computer-assisted methods (repeated multiple point-to-point vs area by length ratio). Results: Reticular basement membrane thickness was higher in severe asthma compared with mild asthma and COPD (P = .0053). On the basis of receiver operating characteristic curves, RBM thickness was effective in differentiating severe asthma from other groups (sensitivity and specificity, 98% and 95%, respectively, above a threshold of 5 μm vs control, 70% and 75% at 7 μm vs mild, 83% and 68% at 6 μm vs COPD). Conclusion: Increased RBM thickness was specifically associated with severe asthma, whereas surprisingly, COPD and mild asthma had similar remodeling features. Clinical implications: Reticular basement membrane thickness can be considered a hallmark of severe asthma. [Copyright &y& Elsevier]- Published
- 2007
- Full Text
- View/download PDF
10. Rheology predicts sputum eosinophilia in patients with muco-obstructive lung diseases.
- Author
-
Volpato, Mathilde, Vialaret, Jerome, Hirtz, Christophe, Petit, Aurélie, Suehs, Carey, Patarin, Jérémy, Matzner-Lober, Eric, Vachier, Isabelle, Molinari, Nicolas, Bourdin, Arnaud, and Charriot, Jeremy
- Subjects
- *
EOSINOPHILIA , *MUCOCILIARY system , *LUNGS , *LUNG diseases , *NUCLEIC acid amplification techniques , *SPUTUM , *RHEOLOGY - Abstract
Mucus is known to play a pathogenic role in muco-obstructive lung diseases, but little is known about the determinants of mucus rheology. The purpose of this study is to determine which sputum components influence sputum rheology in patients with muco-obstructive lung diseases. We performed a cross sectional prospective cohort study. Spontaneous sputum was collected from consecutive patients with muco-obstructive lung diseases. Sputum rheology was assessed using the Rheomuco® rheometer (Rheonova, Grenoble); the elastic modulus G′, viscous modulus G″, and the critical stress threshold σc were recorded. Key quantitative and qualitative biological sputum components were determined by cytology, nucleic acid amplification tests and mass spectrometry. 48 patients were included from January to August 2019. Among them, 10 had asthma, 14 COPD and 24 non-CF bronchiectasis (NCFB). The critical stress threshold σc predicted a sputum eosinophilia superior to 1.25% with 89.19% accuracy (AUC = 0.8762). G′ and G″ are positively correlated with MUC5AC protein concentration ((rho = 0.361; P =.013) and (rho = 0.335; P =.021), respectively). σc was positively correlated with sputum eosinophilia (rho = 0.394; P =.012), MUC5B (rho = 0.552; P <.001) and total protein (rho = 0.490; P <.001) concentrations. G′ and G″ were significantly higher in asthma patients (G' = 14.49[7.18–25.26]Pa, G'' = 3.0[2.16–5.38]Pa) compared to COPD (G' = 5.01[2.94–6.48]Pa, P =.010; G'' = 1.45[1.16–1.94]Pa, P =.006) and to NCFB (G' = 4.99[1.49–10.49]Pa, P =.003; G" = 1.46[0.71–2.47]Pa, P =.002). In muco-obstructive lung diseases, rheology predicts sputum eosinophilia and is correlated with mucin concentrations, regardless of the underlying disease. (registrar, website, and registration number), where applicable NCT04081740. • Sputum rheology is correlated with mucin content and eosinophils. • Critical stress threshold predicts sputum eosinophilia >1.25% regardless of the underlying disease. • Rheology-based diagnosis and therapeutic strategies can now be tested. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.